DiaSorin S.p.A. (BIT: DIA)
Italy
· Delayed Price · Currency is EUR
101.90
+1.40 (1.39%)
Jan 17, 2025, 5:35 PM CET
DiaSorin Revenue
DiaSorin had revenue of 287.00M EUR in the quarter ending September 30, 2024, with 6.30% growth. This brings the company's revenue in the last twelve months to 1.18B, down -1.42% year-over-year. In the year 2023, DiaSorin had annual revenue of 1.15B, down -15.64%.
Revenue (ttm)
1.18B
Revenue Growth
-1.42%
P/S Ratio
4.61
Revenue / Employee
367.16K
Employees
3,233
Market Cap
5.43B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.15B | -212.93M | -15.64% |
Dec 31, 2022 | 1.36B | 123.48M | 9.98% |
Dec 31, 2021 | 1.24B | 356.35M | 40.43% |
Dec 31, 2020 | 881.31M | 174.99M | 24.77% |
Dec 31, 2019 | 706.32M | 37.12M | 5.55% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Recordati Industria Chimica e Farmaceutica | 2.27B |
Amplifon | 2.36B |
EL.En. | 665.50M |
Philogen | 3.92M |
Pharmanutra | 113.13M |
Safilo Group | 1.01B |
GPI S.p.A. | 484.01M |
Shedir Pharma Group | 60.96M |
DiaSorin News
- 5 weeks ago - DiaSorin S.p.A. 2024 Q3 - Results - Earnings Call Presentation - Seeking Alpha
- 2 months ago - Diasorin SpA (WBO:DIAS) Q3 2024 Earnings Call Highlights: Strong Growth Amidst Challenges - GuruFocus
- 2 months ago - Diagnostics group DiaSorin's nine-month adjusted core profit up 6% - Reuters
- 6 months ago - DiaSorin S.p.A. (DSRLF) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 11 months ago - DiaSorin S.p.A. (DSRLF) Q4 2023 Earnings Call Transcript - Seeking Alpha
- 11 months ago - Diasorin 2023 revenue drops 14%, in line with guidance; shares fall - Reuters
- 1 year ago - DiaSorin S.p.A. (DSRLF) Q3 2023 Earnings Call Transcript - Seeking Alpha
- 1 year ago - DiaSorin S.p.A. (DSRLF) Q2 2023 Earnings Call Transcript - Seeking Alpha